Luis Rodriguez

Dr. Luis Rodriguez

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2024 in Science
Verified
Journal Article
Closed access
DJDakota L. Jones
Dakota L. Jones
MMMichael P. Morley
Michael P. Morley
XLXinyuan Li
Xinyuan Li
YYYun Ying
Yun Ying
GZGan Zhao
Gan Zhao
EMEdward E. Morrisey
Edward E. Morrisey
Severe lung injury causes airway basal stem cells to migrate and outcompete alveolar stem cells, resulting in dysplastic repair. We found that this “stem cell collision” generates an injury-induced tissue niche containing keratin 5 + epithelial cells and plastic Pdgfra + mesenchymal cells. Single-cell analysis revealed that the injury-induced niche is governed by mesenchymal proliferation and Notch signaling, which suppressed Wnt/Fgf signaling in the injured niche. Conversely, loss of Notch signaling rewired alveolar signaling patterns to promote functional regeneration and gas exchange. Signaling patterns in injury-induced niches can differentiate fibrotic from degenerative human lung diseases through altering the direction of Wnt/Fgf signaling. Thus, we have identified an injury-induced niche in the lung with the ability to discriminate human lung disease phenotypes.

5 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LRLuis Rodriguez
Luis Rodriguez
MEMargaret Emblom-Callahan
Margaret Emblom-Callahan
MCMantej Chhina
Mantej Chhina
SBSarah Bui
Sarah Bui
BABilal Aljeburry
Bilal Aljeburry
GGGeraldine M. Grant
Geraldine M. Grant
Idiopathic Pulmonary Fibrosis (IPF) is a progressive disorder that is marked by an over accumulation of activated fibroblast populations. Despite the improved understanding of many mechanisms within this disease, global gene expression analysis has few focused studies on the fibroblast, the central effector cell of progressive fibrosis. We present a unique analysis of IPF pulmonary fibroblasts as they transition through cell culture and identify in vitro altered cellular processes. Fibroblasts were isolated from diseased (n = 8) and non-diseased (n = 4) lungs. Global gene expression analysis was carried out at the initial point of isolation and after 3 weeks of culture. We identify several genes that are altered by removal of the fibroblast from the IPF environment. Comparison of this subset of genes to four previously published whole lung analyses refined our list to a small subset of key fibroblast specific genes important in IPF. Application of STRING database analysis and confirmation via in-vitro and histological assay highlights the CXCL14/CXCR4 chemokine axis with a possible role in the progression and/or activation of fibroblasts within the IPF lung. Our findings, present a possible therapeutic target for IPF and a model for the study and discovery of novel protein and processes in this terrible disease.

29 August 2013 in The Journal of Molecular Diagnostics
Verified
Journal Article
Open access
PDF file
KQKevin Qu
Kevin Qu
QPQiulu Pan
Qiulu Pan
XZXi Zhang
Xi Zhang
LRLuis Rodriguez
Luis Rodriguez
KZKe Zhang
Ke Zhang
FWFrederic Waldman
Frederic Waldman
Melanoma is one of the most common cancers in the United States and appears to be increasing in incidence.1 x 1 Simard, E.P., Ward, E.M., Siegel, R., and Jemal, A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012; 62: 118–128 Crossref | Scopus (430) | Google Scholar See all References , 2 x 2 Cokkinides, V.E., Geller, A.C., and Jemal, A. Trends in melanoma mortality among non-Hispanic whites by educational attainment, 1993–2007. Arch Dermatol. 2012; 148: 587–591 Crossref | PubMed | Scopus (10) | Google Scholar See all References , 3 x 3 Jemal, A., Saraiya, M., Patel, P., Cherala, S.S., Barnholtz-Sloan, J., Kim, J., Wiggins, C.L., and Wingo, P.A. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol. 2011; 65: S17–S25 Abstract | Full Text | Full Text PDF | PubMed | Scopus (228) | Google Scholar See all References Although melanoma is the most aggressive form of skin cancer, it remains highly curable if it is detected early: 5-year survival is approximately 90% overall and exceeds 98% when disease is detected at the localized stage (84% of cases).4 x 4 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al (eds). SEER Cancer Statistics Review 1975-2009. Table 16.8 Melanoma of the Skin (Invasive): 5-Year Relative and Period Survival (Percent) by Race, Sex, Diagnosis Year, Stage and Age. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2009_pops09/browse_csr.php?section=16&page=sect_16_table.08.html. Accessed July 17, 2012. Google Scholar See all References However, approximately 4% of melanoma cases are diagnosed after distant metastasis, when 5-year survival is only 15%4 x 4 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al (eds). SEER Cancer Statistics Review 1975-2009. Table 16.8 Melanoma of the Skin (Invasive): 5-Year Relative and Period Survival (Percent) by Race, Sex, Diagnosis Year, Stage and Age. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2009_pops09/browse_csr.php?section=16&page=sect_16_table.08.html. Accessed July 17, 2012. Google Scholar See all References ; median survival in patients with metastatic disease is <1 year.5 x 5 Altekruse, S.F., Kosary, C.L., Krapcho, M., Neyman, N., Aminou, R., and Waldron, W. 2010 SEER Cancer Statistics Review, 1975–2007. National Cancer Institute, Bethesda; 2010 Google Scholar See all References Increased knowledge of the molecular changes that drive cancer development can allow development of targeted therapeutics that can improve survival in patients with advanced melanoma.6 x 6 Chapman, P.B., Hauschild, A., Robert, C., Haanen, J.B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., Hogg, D., Lorigan, P., Lebbe, C., Jouary, T., Schadendorf, D., Ribas, A., O’Day, S.J., Sosman, J.A., Kirkwood, J.M., Eggermont, A.M., Dreno, B., Nolop, K., Li, J., Nelson, B., Hou, J., Lee, R.J., Flaherty, K.T., and McArthur, G.A. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011; 364: 2507–2516 Crossref | PubMed | Scopus (4607) | Google Scholar See all References , 7 x 7 Hauschild, A., Grob, J.J., Demidov, L.V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C.U., Miller, W.H. Jr., Kaempgen, E., Martin-Algarra, S., Karaszewska, B., Mauch, C., Chiarion-Sileni, V., Martin, A.M., Swann, S., Haney, P., Mirakhur, B., Guckert, M.E., Goodman, V., and Chapman, P.B. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet. 2012; 380: 358–365 Abstract | Full Text | Full Text PDF | PubMed | Scopus (1657) | Google Scholar See all References

17 October 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JKJeremy Katzen
Jeremy Katzen
LRLuis Rodriguez
Luis Rodriguez
YTYaniv Tomer
Yaniv Tomer
ABApoorva Babu
Apoorva Babu
MZMing Zhao
Ming Zhao
MBMichael F. Beers
Michael F. Beers
Disruption of alveolar type 2 cell (AEC2) protein quality control has been implicated in chronic lung diseases, including pulmonary fibrosis (PF). We previously reported the in vivo modeling of a clinical surfactant protein C (SP-C) mutation that led to AEC2 endoplasmic reticulum (ER) stress and spontaneous lung fibrosis, providing proof of concept for disruption to proteostasis as a proximal driver of PF. Using two clinical SP-C mutation models, we have now discovered that AEC2s experiencing significant ER stress lose quintessential AEC2 features and develop a reprogrammed cell state that heretofore has been seen only as a response to lung injury. Using single-cell RNA sequencing in vivo and organoid-based modeling, we show that this state arises de novo from intrinsic AEC2 dysfunction. The cell-autonomous AEC2 reprogramming can be attenuated through inhibition of inositol-requiring enzyme 1 (IRE1α) signaling as the use of an IRE1α inhibitor reduced the development of the reprogrammed cell state and also diminished AEC2-driven recruitment of granulocytes, alveolitis, and lung injury. These findings identify AEC2 proteostasis, and specifically IRE1α signaling through its major product XBP-1, as a driver of a key AEC2 phenotypic change that has been identified in lung fibrosis.

30 September 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
EHEvan T. Hoffman
Evan T. Hoffman
ASAnit Shah
Anit Shah
WBWilly Roque Barboza
Willy Roque Barboza
LRLuis Rodriguez
Luis Rodriguez
RDRachna Dherwani
Rachna Dherwani
JKJeremy Katzen
Jeremy Katzen
Pulmonary fibrosis (PF) is a progressive disease histologically defined by pathological fibroblasts and epithelial cells. PF lungs contain alveolar type 2 epithelial cells (AT2s) that acquire an aberrant intermediate state phenotype. However, the direct role of these cells in PF and the signals causing them to arise and persist are not fully known. To address this, we harness the SftpcC121G mouse model, where expression of a PF-associated mutation in the AT2-specific surfactant protein C (Sftpc) gene results in AT2 dysfunction and spontaneous lung fibrosis. Here, we identify aberrant intermediate epithelial cells in SftpcC121G lungs that share transcriptional profiles with human PF aberrant basaloid cells and develop a profibrotic interactome with fibroblasts. We develop a sorting method to enrich for these cells, and through ex vivo assays, identify a profibrotic secretome mediated by TGF-β signaling. Coupling this murine model with a newly developed patient-specific induced pluripotent stem cell-derived mutant SFTPC model, we discover that human SFTPC-mutant AT2s express an aberrant basaloid program, and that loss of canonical progenitor signals coupled with TGF-β stimulation causes AT2s to enter this state. We conclude that aberrant intermediate epithelial cells drive pathogenic fibroblast activation, and that reciprocal signaling contributes to their entry into this profibrotic state.

16 June 2021 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
PDF file
YTYaniv Tomer
Yaniv Tomer
JWJennifer Wambach
Jennifer Wambach
LKLars Knudsen
Lars Knudsen
MZMing Zhao
Ming Zhao
LRLuis Rodriguez
Luis Rodriguez
SMSurafel Mulugeta
Surafel Mulugeta
ATP-binding cassette class A3 (ABCA3) is a lipid transporter that plays a critical role in pulmonary surfactant function. The substitution of valine for glutamic acid at codon 292 (E292V) produces a hypomorphic variant that accounts for a significant portion of ABCA3 mutations associated with lung disorders spanning from neonatal respiratory distress syndrome and childhood interstitial lung disease to diffuse parenchymal lung disease (DPLD) in adults including pulmonary fibrosis. The mechanisms by which this and similar ABCA3 mutations disrupt alveolar type 2 (AT2) cell homeostasis and cause DPLD are largely unclear. The present study, informed by a patient homozygous for the E292V variant, used an in vitro and a preclinical murine model to evaluate the mechanisms by which E292V expression promotes aberrant lung injury and parenchymal remodeling. Cell lines stably expressing enhanced green fluorescent protein (EGFP)-tagged ABCA3 isoforms show a functional deficiency of the ABCA3E292V variant as a lipid transporter. AT2 cells isolated from mice constitutively homozygous for ABCA3E292V demonstrate the presence of small electron-dense lamellar bodies, time-dependent alterations in macroautophagy, and induction of apoptosis. These changes in AT2 cell homeostasis are accompanied by a spontaneous lung phenotype consisting of both age-dependent inflammation and fibrillary collagen deposition in alveolar septa. Older ABCA3E292V mice exhibit increased vulnerability to exogenous lung injury by bleomycin. Collectively, these findings support the hypothesis that the ABCA3E292V variant is a susceptibility factor for lung injury through effects on surfactant deficiency and impaired AT2 cell autophagy.